Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

NCT02914548 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: OPA-15406
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Co., Ltd.